Approvals/CIMA-AEMPS/EXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

EXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Advanz Pharma Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 570dda5e22f097ee
Drug Cima Aemps Name: EXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1241794001
Holder Company Name: Advanz Pharma Limited
Marketing Company Name: Advanz Pharma Spain S.L.U.
Holder Company Detail Path: /organization/advanz-pharma-international-limited
Authorization Date: 2024-04-04
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2 g/0,5 g
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Advanz Pharma Limited
Company Detail Path: /organization/advanz-pharma-international-limited

CEFEPIMA DIHIDROCLORURO MONOHIDRATO

2378 mg

ENMETAZOBACTAM

500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 4, 2024

Approval ID

570dda5e22f097ee

Type

Standard